ATAI vs OXY
ATAI Life Sciences BV (ATAI) versus OXY (OXY) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
OXY (OXY) common stock.
Latest reported ATAI revenue for 2024-12-31 was $308.0K. Net income was -$150.0M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. ATAI currently screens at market cap $555.8M.
OXY does not have a complete income-statement cache yet.
ATAI currently screens at market cap $555.8M. OXY currently screens at market cap $0.
Not investment advice. Open the ATAI and OXY stock pages for the full models.
Not investment advice.